Kesios Therapeutics raised €27M in a Series A round in Dec 2015. The company is based in London, UK. Investors in the round: Abingworth LLP, Imperial Innovations Limited, SV Life Sciences. Data as of 7 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
